ConductScience.org, home

Paper41299124

Primary Care Providers Perspectives of GLP-1 Receptor Agonists to Manage Recurrent Weight Gain after Metabolic Bariatric Surgery - a Qualitative Study.

Tolvanen L and 6 others. Obes Surg, 2026. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Primary Care Providers Perspectives of GLP-1 Receptor Agonists to Manage Recurrent Weight Gain after Metabolic Bariatric Surgery - a Qualitative Study. Papers, record 41299124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41299124

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Primary Care Providers Perspectives of GLP-1 Receptor Agonists to Manage Recurrent Weight Gain after Metabolic Bariatric Surgery - a Qualitative Study.
PubMed
Journal
Obes Surg
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-01-31
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tolvanen LLiisa
2Mossberg KKarin
3Grace LMLindsey M
4Standen ECErin C
5Phelan SMSean M
6Andersson DPDaniel P
7Koball AMAfton M

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bariatric SurgeryMajor topic
Glucagon-Like Peptide-1 Receptor AgonistsMajor topic
Weight GainMajor topic
Attitude of Health PersonnelMajor topic
Physicians, Primary CareMajor topic
Humans
Qualitative Research
Female
Male
Middle Aged
Primary Health Care
Adult
United States
Recurrence
Sweden

Source PubMed

Download CSV of topics

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139907856The Impact of Novel Medications for Obesity on Weight Stigma and Societal Attitudes: A Narrative Review.Curr Obes Rep2025https://conductscience.org/library/papers/39907856PubMed
227222548Clinical Outcomes of Metabolic Surgery: Efficacy of Glycemic Control, Weight Loss, and Remission of Diabetes.Diabetes Care2016https://conductscience.org/library/papers/27222548PubMed
340712620International Federation for the Surgery of Obesity statement on metabolic bariatric surgery after pharmacotherapy-induced weight loss in clinical obesity.Lancet Diabetes Endocrinol2025https://conductscience.org/library/papers/40712620PubMed
435658024Tirzepatide Once Weekly for the Treatment of Obesity.N Engl J Med2022https://conductscience.org/library/papers/35658024PubMed
5363367202022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery.Obes Surg2023https://conductscience.org/library/papers/36336720PubMed
639910018The Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists for Insufficient Weight Loss or Regain After Metabolic/Bariatric Surgery: A Systematic Review and Meta-analysis.Obes Surg2025https://conductscience.org/library/papers/39910018PubMed
738561488The effect of GLP-1 receptor agonist use on negative evaluations of women with higher and lower body weight.Int J Obes (Lond)2024https://conductscience.org/library/papers/38561488PubMed
838660941Managing the new wave of weight loss medication in general practice: A qualitative study.Clin Obes2024https://conductscience.org/library/papers/38660941PubMed
933567185Once-Weekly Semaglutide in Adults with Overweight or Obesity.N Engl J Med2021https://conductscience.org/library/papers/33567185PubMed
1038969880A new framework for the diagnosis, staging and management of obesity in adults.Nat Med2024https://conductscience.org/library/papers/38969880PubMed
1117356530Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study.Int J Obes (Lond)2007https://conductscience.org/library/papers/17356530PubMed
1239612579
International consensus position statement on the role of obesity management medications in the context of metabolic bariatric surgery: expert guideline by the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).
Br J Surg2024https://conductscience.org/library/papers/39612579PubMed
1338848064Bariatric Metabolic Surgery vs Glucagon-Like Peptide-1 Receptor Agonists and Mortality.JAMA Netw Open2024https://conductscience.org/library/papers/38848064PubMed
1440316896Barriers in prescribing antidiabetic medications with cardiovascular benefits: practice, experience, and attitudes of GPs in Croatia.BMC Prim Care2025https://conductscience.org/library/papers/40316896PubMed
1539657161Behavioral medicine in the GLP-1 era.Ann Behav Med2025https://conductscience.org/library/papers/39657161PubMed
1640692948Primary care patient and practice member perspectives on weight loss medications: challenges and opportunities.Front Med (Lausanne)2025https://conductscience.org/library/papers/40692948PubMed
1739781548Perceptions of Obesity Among Healthcare Professionals and Policy Makers in 2023: Results of the Global OPEN Survey.Obes Sci Pract2025https://conductscience.org/library/papers/39781548PubMed
1839400870Therapeutic Options for Recurrence of Weight and Obesity Related Complications After Metabolic and Bariatric Surgery: An IFSO Position Statement.Obes Surg2024https://conductscience.org/library/papers/39400870PubMed
1938708040Healthcare professionals' perceptions and management of obesity & knowledge of glucagon, GLP-1, GIP receptor agonists, and dual agonists.Obes Sci Pract2024https://conductscience.org/library/papers/38708040PubMed
2039612581Role of obesity-management medications before and after metabolic bariatric surgery: a systematic review.Br J Surg2024https://conductscience.org/library/papers/39612581PubMed

See all 28 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42533869Understanding obesity treatment choices: a mixed-methods study of patient preferences and shared decision-making.Transl Behav Med2026https://conductscience.org/library/papers/42533869PubMed
42076118Is Oral Semaglutide a Good Fit for Patients After Metabolic Bariatric Surgery? A Biopharmaceutical Mechanistic Perspective.Pharmaceutics2026https://conductscience.org/library/papers/42076118PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
GLP1R2740PubTator's text mininghttps://conductscience.org/library/genes/2740

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41299124

GET https://conductscience.org/api/papers/v1/41299124/references?page=2